Madrigal Pharmaceuticals ... (MDGL)
NASDAQ: MDGL
· Real-Time Price · USD
369.75
-1.62 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
344.50
-6.83%
After-hours: Aug 15, 2025, 07:58 PM EDT
Madrigal Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 191.19M | 183.65M | 100.02M | 232.68M | 499.6M | 622.52M | 99.92M | 62.05M | 77.2M | 113.31M | 331.55M | 59.34M | 53.27M | 42.28M | 36.27M | 49.17M | 33.54M | 44.2M |
Short-Term Investments | 610.83M | 659.42M | 826.23M | 765.94M | 563.2M | 436.55M | 534.22M | 170.3M | 221.22M | 216.17M | 27.23M | 93.85M | 158.49M | 177.67M | 234.08M | 249.97M | 290.31M | 263.02M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 79.23M | 61.43M | 53.82M | 30.46M | 6.9M | -14.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 63.5M | 55.24M | 34.07M | 8.71M | 7.07M | 854K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 58.6M | 28.24M | 18.79M | 25.86M | 5M | 14.04M | 3.15M | 3.12M | 3.18M | 1.81M | 2.6M | n/a | n/a | n/a | 1.34M | n/a | n/a | 822K |
Total Current Assets | 1B | 987.98M | 1.03B | 1.06B | 1.09B | 1.07B | 637.28M | 235.47M | 301.6M | 331.28M | 361.37M | 157.11M | 214.55M | 221.17M | 271.68M | 302.96M | 326.07M | 308.05M |
Property-Plant & Equipment | 7.48M | 4.01M | 4.59M | 4.78M | 3.15M | 3.33M | 3.27M | 2.5M | 866K | 1.17M | 1.2M | 1.53M | 1.85M | 1.49M | 1.65M | 1.74M | 1.89M | 1.69M |
Goodwill & Intangibles | 4.55M | 4.64M | 4.73M | 4.82M | 4.91M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.02M | 8.65M | 9.32M | 9.6M | 8.06M | 8.33M | 3.27M | 2.5M | 866K | 1.17M | 1.2M | 1.53M | 1.85M | 1.49M | 1.65M | 1.74M | 1.89M | 1.69M |
Total Assets | 1.02B | 996.63M | 1.04B | 1.07B | 1.1B | 1.08B | 640.55M | 237.96M | 302.46M | 332.45M | 362.57M | 158.64M | 216.39M | 222.66M | 273.33M | 304.7M | 327.95M | 309.73M |
Account Payables | 37.98M | 42.06M | 43.6M | 45.97M | 8.99M | 21.53M | 28.04M | 16.54M | 17.53M | 12.13M | 23.83M | 18.56M | 11.29M | 22.78M | 21.38M | 10.42M | 1.07M | 4.4M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.05M | 1.02M | n/a | 878K | n/a | 542K | 527K | 513K | 411K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 129.79M | 105.89M | 34.96M | 101.32M | n/a | 74.78M | 72.42M | 72.13M | 75.9M | 74.36M | n/a | 74.55M | n/a | 50.73M | 6.77M | 4.97M | 51.66M | 41.19M |
Total Current Liabilities | 196.5M | 167.24M | 169.28M | 177.85M | 125.16M | 114.34M | 118.55M | 99.67M | 99.71M | 98.35M | 115.89M | 98.92M | 84.01M | 76.64M | 76.84M | 69.33M | 56.71M | 48.79M |
Long-Term Debt | 118.38M | 118M | 117.57M | 117.09M | 116.61M | 116.14M | 115.48M | 114.73M | 99.25M | 83.97M | 49.29M | 48.98M | 48.67M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 122.9M | 118.75M | 118.59M | 118.26M | 117.51M | 117.18M | 116.67M | 116.05M | 99.25M | 83.97M | 49.29M | 49.05M | 48.85M | 283K | 387K | 491K | 594K | 387K |
Total Liabilities | 319.4M | 285.99M | 287.86M | 296.11M | 242.67M | 231.52M | 235.21M | 215.72M | 198.96M | 182.31M | 165.18M | 147.97M | 132.86M | 76.92M | 77.22M | 69.82M | 57.3M | 49.18M |
Total Debt | 123.95M | 119.77M | 119.57M | 119.14M | 118.06M | 117.72M | 117.19M | 116.56M | 99.66M | 84.62M | 49.89M | 49.81M | 49.73M | 696K | 797K | 897K | 997K | 707K |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
Retained Earnings | -1.92B | -1.88B | -1.8B | -1.74B | -1.64B | -1.48B | -1.34B | -1.22B | -1.13B | -1.04B | -962.66M | -876.75M | -795.56M | -724.83M | -667.31M | -602.76M | -539.66M | -478.01M |
Comprehensive Income | 1.11M | 389K | 468K | 1.27M | -368K | -172K | 468K | -42K | -89K | -86K | -32K | -237K | -447K | -402K | -80K | 4K | 15K | -14K |
Shareholders Equity | 695.98M | 710.64M | 754.38M | 777.15M | 857.12M | 850.76M | 405.33M | 22.25M | 103.51M | 150.14M | 197.39M | 10.67M | 83.53M | 145.74M | 196.11M | 234.88M | 270.65M | 260.55M |
Total Investments | 610.83M | 659.42M | 826.23M | 765.94M | 563.2M | 436.55M | 534.22M | 170.3M | 221.22M | 216.17M | 27.23M | 93.85M | 158.49M | 177.67M | 234.08M | 249.97M | 290.31M | 263.02M |